Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteogenesis imperfecta.

J M Gertner1, L Root

  • 1Cornell University Medical College, New York, New York.

The Orthopedic Clinics of North America
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Osteogenesis imperfecta (OI) is a group of heritable bone disorders causing fragility and low bone mass. Current treatments focus on orthopedic care, with limited pharmacologic options and growing potential for prenatal diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.

Pediatrics·2001
Same author

A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta.

Calcified tissue international·2001
Same author

Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry.

Pediatrics·2001
Same author

Current age of onset of puberty.

Pediatrics·2000
Same author

Osteoporosis: an unusual presentation of childhood Crohn's disease.

The Journal of clinical endocrinology and metabolism·2000
Same author

Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH.

Endocrinology·2000
Same journal

New Technologies.

The Orthopedic clinics of North America·2026
Same journal

Recent Innovations and Applications of Custom 3D Printed Cages for Critical Bone Defects in Foot and Ankle Surgery.

The Orthopedic clinics of North America·2026
Same journal

Application of New Technologies: Patient-specific Instrumentation and Artificial Intelligence in the Field of Foot and Ankle.

The Orthopedic clinics of North America·2026
Same journal

Robotic-Assisted Latissimus Dorsi Transfers Around the Shoulder.

The Orthopedic clinics of North America·2026
Same journal

Blood Flow Restriction Therapy for the Upper Extremity: An Emerging Adjunct for Patient Recovery and Rehabilitation.

The Orthopedic clinics of North America·2026
Same journal

The Emerging Roles for 3 Dimensional Printing in Orthopedics: Applications, Evidence, and Future Directions.

The Orthopedic clinics of North America·2026
See all related articles

Area of Science:

  • Genetics
  • Orthopedics
  • Molecular Biology

Background:

  • Osteogenesis imperfecta (OI) is a group of heritable disorders characterized by extreme bone fragility and reduced skeletal mass.
  • While clinically classified, the underlying genetic defects in collagen synthesis are increasingly understood.
  • Current understanding of OI is rapidly evolving, particularly regarding its genetic basis.

Purpose of the Study:

  • To review the clinical manifestations and genetic basis of Osteogenesis Imperfecta.
  • To discuss current nonoperative and surgical orthopedic management strategies for OI.
  • To evaluate the efficacy of pharmacologic agents and the potential of prenatal diagnosis for OI.

Main Methods:

  • Review of existing literature on Osteogenesis Imperfecta.

Related Experiment Videos

  • Analysis of clinical classifications and genetic defects.
  • Assessment of orthopedic interventions and pharmacologic treatments.
  • Evaluation of prenatal diagnostic approaches.

    • Main Results:

    • OI is characterized by bone fragility and low bone mass, with diverse clinical presentations.
    • Rapid advancements are being made in understanding the genetic defects in collagen synthesis.
    • Orthopedic approaches aim to preserve limb strength and correct deformities.
    • No pharmacologic agents have proven effective in controlled trials for OI.
    • Prenatal diagnosis for OI is feasible and expected to become more important.

    Conclusions:

    • Osteogenesis Imperfecta management relies on orthopedic interventions to maintain function.
    • Pharmacologic treatments for OI have not yet demonstrated efficacy in clinical trials.
    • Advances in molecular genetics are enhancing the potential for prenatal diagnosis of OI.